83
68
Growth Score 83 in past quarter
-2 pts
Heat Score 68 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
635464
AETAS Pharma is a pharmaceutical company that specializes in research and development and licensing.
- Shunsuke Tsuji: President and CEO
- Kaneko Noboru: Representative Director
About the Company
AETAS Pharma is a pharmaceutical company that specializes in research and development and licensing.
Since its establishment in May 2000, the company has been engaged in drug discovery research and development for substances that have the effect of improving cardiac function and renal function. Especially for the development of atrial
fibrillation therapeutics in heart disease, it is a pipeline that has been vigorously promoted since its establishment, and there is no definitive therapeutic at present, and we are developing a developed formulation for patients who are suffering.
